Cellebrite DI Analyst Price Targets - Benzinga

Cellebrite DI Ltd

CLBTNASDAQ

Trade with Public

Trade with Public

$12.15

0.020.16%

Ult. Agg.: Nov 3, 11:06 AM

Panoramica Notizie Previsioni utili EventiObiettivi di prezzoDati finanziari Sentiment Azionariato Confronta Opzioni Rapporto azionario

© 2026 Benzinga | All Rights Reserved

Cellebrite DI Analyst Price Targets

Wall Street analyst price targets and consensus rating for Cellebrite DI (CLBT).

Price Target Range — 11 Quarters

Analyst Consensus — 9 Analysts

9Buy

Consensus RatingBuy# Analysts9Avg. Consensus PT$19Upside to Avg. PT+53.5%

Rating Trend — Last 9 Months

Recent Analyst Actions

Visualizza tutte le valutazioni →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 15, 2026	DA Davidson	Rudy Kessinger	Maintained	Buy	$15
Aug 14, 2026	Lake Street	Eric Martinuzzi	PT Cut	Buy	$21→$15
Aug 14, 2026	JP Morgan	Brian Essex	PT Cut	Overweight	$20→$16
Aug 14, 2026	DA Davidson	Rudy Kessinger	PT Cut	Buy	$22→$15
Aug 14, 2026	Needham	Mike Cikos	PT Cut	Buy	$15→$13
Aug 6, 2026	DA Davidson	Rudy Kessinger	PT Raise	Buy	$20→$22
May 27, 2026	DA Davidson	Rudy Kessinger	Initiate	Buy	$20
May 15, 2026	Needham	Mike Cikos	PT Cut	Buy	$18→$15
Feb 12, 2026	Needham	Mike Cikos	PT Cut	Buy	$24→$18
Nov 13, 2025	JP Morgan	Brian Essex	PT Raise	Overweight	$23→$24
Nov 13, 2025	Lake Street	Eric Martinuzzi	PT Raise	Buy	$22→$23
Nov 13, 2025	B of A Securities	Tal Liani	PT Raise	Buy	$24→$25
Nov 13, 2025	Needham	Mike Cikos	PT Raise	Buy	$22→$24
Sep 24, 2025	JP Morgan	Brian Essex	PT Raise	Overweight	$20→$23
Aug 15, 2025	Lake Street	Eric Martinuzzi	PT Cut	Buy	$24→$22
Aug 14, 2025	Needham	Mike Cikos	PT Cut	Buy	$24→$18
Jun 23, 2025	JP Morgan	Brian Essex	PT Cut	Overweight	$22→$20
Jun 6, 2025	Needham	Mike Cikos	Maintained	Buy	$24
May 15, 2025	JP Morgan	Brian Essex	PT Cut	Overweight	$25→$22
May 14, 2025	Needham	Mike Cikos	PT Cut	Buy	$28→$24

Analyst Ratings News

PRO
Lake Street Maintains Buy on Cellebrite DI, Lowers Price Target to $15

Lake Street analyst Eric Martinuzzi maintains Cellebrite DI (NASDAQ:CLBT) with a Buy and lowers the price target from $21 to $15.

Benzinga Newsdesk

PRO
JP Morgan Maintains Overweight on Cellebrite DI, Lowers Price Target to $16

JP Morgan analyst Brian Essex maintains Cellebrite DI (NASDAQ:CLBT) with a Overweight and lowers the price target from $20 to $16.

Benzinga Newsdesk

PRO
DA Davidson Maintains Buy on Cellebrite DI, Lowers Price Target to $15

DA Davidson analyst Rudy Kessinger maintains Cellebrite DI (NASDAQ:CLBT) with a Buy and lowers the price target from $22 to $15.

Benzinga Newsdesk

PRO
Needham Maintains Buy on Cellebrite DI, Lowers Price Target to $12.5

Needham analyst Mike Cikos maintains Cellebrite DI (NASDAQ:CLBT) with a Buy and lowers the price target from $15 to $12.5.

Benzinga Newsdesk

PRO
DA Davidson Maintains Buy on Cellebrite DI, Raises Price Target to $22

DA Davidson analyst Rudy Kessinger maintains Cellebrite DI (NASDAQ:CLBT) with a Buy and raises the price target from $20 to $22.

Benzinga Newsdesk

PRO
DA Davidson Initiates Coverage On Cellebrite DI with Buy Rating, Announces Price Target of $20

DA Davidson analyst Rudy Kessinger initiates coverage on Cellebrite DI (NASDAQ:CLBT) with a Buy rating and announces Price Target of $20.

Benzinga Newsdesk